Belpointe Asset Management LLC Viatris Inc Transaction History

Belpointe Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$11.27 - $13.53 $27,927 - $33,527	-2,478 Reduced 19.41%	10,288 $122,000
Q4 2023 Feb 13, 2024	BUY	$8.77 - $10.85 $13,216 - $16,350	1,507 Added 13.38%	12,766 $138,000
Q3 2023 Nov 15, 2023	BUY	$9.59 - $11.35 $10,261 - $12,144	1,070 Added 10.5%	11,259 $111,000
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $33,888 - $38,659	3,757 Added 58.41%	10,189 $101,000
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $20,497 - $27,315	2,228 Added 53.0%	6,432 $61,000
Q4 2022 Feb 08, 2023	BUY	$8.72 - $11.56 $36,658 - $48,598	4,204 New	4,204 $46,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $199,664 - $272,389	-14,692 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $210,095 - $275,328	14,692 New	14,692 $275,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.